BMRA vs ABT: Which Stock is Better?
Side-by-side comparison of Biomerica Inc and Abbott Laboratories in 2026
BMRA
Biomerica Inc
$2.56
ABT
Abbott Laboratories
$121.14
Key Metrics Comparison
| Metric | BMRA | ABT | Winner |
|---|---|---|---|
| Market Cap | $7.37M | $210.84B | ABT |
| P/E Ratio | N/A | 15.22 | ABT |
| EPS (TTM) | $N/A | $7.96 | ABT |
| Revenue Growth | -0.2% | 0.1% | ABT |
| Gross Margin | 13.0% | 56.3% | ABT |
Analyze BMRA
Full quant analysis
Analyze ABT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is BMRA or ABT a better investment?
Comparing BMRA and ABT: Biomerica Inc has a market cap of $7.37M while Abbott Laboratories has $210.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between BMRA and ABT?
BMRA (Biomerica Inc) and ABT (Abbott Laboratories) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: BMRA or ABT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: BMRA or ABT?
ABT has higher revenue growth at 0.1% vs -0.2% for BMRA.
Which company is more profitable: BMRA or ABT?
Abbott Laboratories (ABT) has higher gross margins at 56.3% compared to 13.0% for BMRA.
Which is the larger company: BMRA or ABT?
Abbott Laboratories (ABT) is larger with a market cap of $210.84B compared to $7.37M for BMRA.
Should I buy BMRA or ABT in 2026?
Both BMRA and ABT have investment merit. BMRA trades at $2.56 while ABT trades at $121.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between BMRA and ABT stock?
Key differences: Market Cap ($7.37M vs $210.84B), P/E Ratio (N/A vs 15.2x), Revenue Growth (-0.2% vs 0.1%), Gross Margin (13.0% vs 56.3%).